$500 Million for Yesterday's Flu Vaccine Is a Bad Bet
The US may spend $500 million reinforcing egg-based flu vaccine manufacturing, a platform invented in the 1940s with efficacy that can drop below 20% in a bad year. mRNA vaccines can be redesigned in days. The choice between them is not really about flu season.
By Vera Santos · 3 min read